HIV prevention drug hailed as breakthrough, but who gets access?

Image: Al Jazeera
ad slot · in-content video 16:9
Coverage
Coverage
- A twice-yearly injection could revolutionise HIV prevention, but who gets access raises bigger questions.
- Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.